Free Trial

Market acting with delayed positive reaction.....>

US
US: Market acting with delayed positive reaction to a new Gilead report on
Remdesivir, which says 74.4% of COVID patients treated with the drug recovered
by day 14 (vs 59% of patients not taking remdesevir), with the mortality rate
7.6% at day 14 (vs 12.5% not taking the drug). S&P futures jumped as much as
0.7% from when that data was released, into positive territory; has retraced
slightly,  last 0.2% lower on the session.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.